Form 4: Edwards Lifesciences CVP Receives RSU Grant

Sentiment:

Insider Transaction Report


Edwards Lifesciences Corporation granted 3,205 restricted stock units to Daveen Chopra, CVP of TMTT & Surgical, as part of its long-term incentive program.

Summary

  • Daveen Chopra, CVP, TMTT & Surgical at Edwards Lifesciences Corp (EW), acquired 3,205 shares of Common Stock.
  • The transaction occurred on September 11, 2025, with a reported price of $0.0000 per share.
  • These shares represent restricted stock units (RSUs) granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program.
  • Following this transaction, Daveen Chopra beneficially owns 34,201 shares of Common Stock.
  • The RSUs are scheduled to vest and become exercisable commencing one year after the grant date (September 11, 2025) in four equal annual installments.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a key executive is a positive signal for executive retention and alignment with shareholder interests, though it's a routine compensation event.

Positives

  • The grant of restricted stock units aligns the executive's interests with long-term shareholder value creation.
  • Participation in the Long-Term Stock Incentive Compensation Program serves as a retention mechanism for key management personnel.

Future Outlook

The granted restricted stock units are scheduled to vest over a four-year period, commencing one year after the grant date, indicating a long-term incentive structure for the executive.

Management Comments

  • The filing reflects changes in beneficial ownership only and does not identify other securities of the Issuer beneficially owned by the Reporting Person.

Industry Context

This is a routine insider transaction related to executive compensation, common across various industries to incentivize long-term performance and retain key talent.

Stakeholder Impact

  • Shareholders: Potential minor dilution over time as RSUs vest, but also improved executive alignment with long-term company performance.
  • Employees (Executive): Enhanced long-term compensation and incentive to contribute to company growth.

Next Steps

  • The restricted stock units will begin vesting one year after the grant date, on September 11, 2026, in four equal annual installments.

Key Dates

DateDescription
09/11/2025Date of RSU grant transaction.
09/15/2025Date the Form 4 was filed.
09/11/2026Commencement of vesting for the granted restricted stock units, occurring in four equal annual installments.

Keywords

Edwards Lifesciences, EW, Daveen Chopra, Restricted Stock Units, RSU Grant, Insider Transaction, Executive Compensation, Stock Incentive Program

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.